The Claim
Transgender women athletes achieve female-typical testosterone concentrations (1.10 ± 0.52 nmol/L) after an average of 5 months of gender-affirming hormone therapy, with significant reductions from pre-therapy levels (18.4 ± 2.8 nmol/L), indicating effective suppression of endogenous androgen production.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Trans women athletes on hormone therapy see their testosterone drop to typical female levels after about 5 months, which shows the treatment is working to lower male hormone levels.
See the scientific wording
Transgender women athletes exhibit female-typical testosterone concentrations (1.10 ± 0.52 nmol/L) after an average of 5 months of gender-affirming hormone therapy, with significant reductions from pre-therapy levels (18.4 ± 2.8 nmol/L), indicating effective suppression of endogenous androgen production.
What the research says
1 studyThe study shows that transgender women on hormone therapy have testosterone levels similar to cisgender women, just like the claim says, so it supports it.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.